Clinical trial
A Randomized, Multi-center, Evaluator and Subject Blind, Active-controlled, Parallel, Medical Device Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Compared to Hyalobarrier Applied to Postoperative Intrauterine
NCT04007211 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multi-center, Evaluator and Subject Blind, Active-controlled, Parallel, Medical Device Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Compared to Hyalobarrier Applied to Postoperative Intrauterine
- Lead sponsor
- Medy-Tox
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 27, 2017
- Completion date
- August 29, 2018
- Enrollment
- 192 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative adhesion of uterus